Robbins Wendye has filed 9 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 49432 shares of RAPT Therapeutics, Inc. ($RAPT) on March 31, 2025.
Activity breakdown: 4 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2025 | RAPT Therapeutics, Inc. | $RAPT | Robbins Wendye | Not found | A | Director Stock Option (right to buy) | 49432 | $1.06 | 49,432.0000 | 132,006,828 | 9999.99% | 0.04% |
| May 22, 2024 | RAPT Therapeutics, Inc. | $RAPT | Robbins Wendye | Not found | A | Stock Option (right to buy) | 36490 | $0.00 | 36,490.0000 | 0 | 9999.99% | 0.00% |
| March 28, 2024 | RAPT Therapeutics, Inc. | $RAPT | Robbins Wendye | Not found | A | Stock Option (right to buy) | 6925 | $7.58 | 6,925.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2023 | RAPT Therapeutics, Inc. | $RAPT | Robbins Wendye | Director | A | Stock Option (right to buy) | 12940 | $0.00 | 12,940.0000 | 0 | 9999.99% | 0.00% |
| March 31, 2023 | RAPT Therapeutics, Inc. | $RAPT | Robbins Wendye | Director | A | Stock Option (right to buy) | 3616 | $14.52 | 3,616.0000 | 0 | 9999.99% | 0.00% |
| March 14, 2023 | RAPT Therapeutics, Inc. | $RAPT | Robbins Wendye | Director | P | Common Stock | 1500 | $18.75 | 26,500.0000 | 0 | 6.00% | 0.00% |
| March 14, 2023 | RAPT Therapeutics, Inc. | $RAPT | Robbins Wendye | Director | P | Common Stock | 400 | $18.48 | 26,900.0000 | 0 | 1.51% | 0.00% |
| March 14, 2023 | RAPT Therapeutics, Inc. | $RAPT | Robbins Wendye | Director | P | Common Stock | 600 | $19.95 | 27,500.0000 | 0 | 2.23% | 0.00% |
| March 14, 2023 | RAPT Therapeutics, Inc. | $RAPT | Robbins Wendye | Director | P | Common Stock | 2500 | $20.05 | 27,500.0000 | 0 | 10.00% | 0.00% |